Lausanne-based Adaptyv raises €34.35 million Series A led by Highland Europe to expand its automated lab for AI-driven protein design.
Amount Raised
€34.4 Million
Round Type
Series A
LausanneBiotechnologyArtificial IntelligenceInvestors
Description
Adaptyv Bio has successfully raised €34.35 million in a Series A funding round to enhance its lab capacity for automated wet lab processes. The round was primarily led by Highland Europe, with significant contributions from existing investors Ace Ventures, ByFounders, and Y Combinator. This funding will allow Adaptyv to tackle more complex biology challenges and support its growth. The startup has seen remarkable expansion, tripling its team and greatly increasing revenue since its Seed round in late 2024.
Quick answer
Adaptyv Bio raised €34.4 Million in a Series A round, dated August 27, 2026. Investors: Byfounders, Ace Ventures, Y Combinator and Highland Europe. Adaptyv Bio is based in Lausanne, Vaud, Switzerland.
- How much did Adaptyv Bio raise?
- Adaptyv Bio raised €34.4 Million in a Series A round on August 27, 2026.
- Who invested in Adaptyv Bio?
- Byfounders, Ace Ventures, Y Combinator and Highland Europe are named as investors in this round.
- What does Adaptyv Bio do?
- Adaptyv Bio is a Lausanne-based BioTech startup focused on building an automated wet lab for AI-driven protein design.
- Where is Adaptyv Bio based and how big is it?
- Adaptyv Bio is based in Lausanne, Vaud, Switzerland.
Source: Fundz verified event record.
Who else raised in Biotechnology and Artificial Intelligence around the same time
Companies in the same sectors as Adaptyv Bio that raised within 45 days of this round, from Fundz verified event records.
- Matter Machine raised $5.3M (Pre-Series A) on October 11, 2026.
- Wavena raised $150K (Seed) on October 8, 2026.
- Peppermint raised $4.7M (Seed) on October 8, 2026.
- Quanfluence raised $10M (Series A) on October 7, 2026.
- Rivercell raised $25M (Seed) on October 7, 2026.
- Cori Clinical raised $4M (Seed) on October 7, 2026.
Who to call at Adaptyv Bio, and when
A new round usually means Adaptyv Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Adaptyv Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Adaptyv Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Adaptyv Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Adaptyv Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansAdaptyv Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.